First-line treatment of metastatic castration-resistant prostate cancer: the real-world Italian cohort of the Prostate Cancer Registry

BACKGROUND: With the availability of multiple treatment options for metastatic castration-resistant prostate cancer (mCRPC), new real-world data on disease management and drugs’ performance are needed. METHODS: We described characteristics, management and clinical outcomes of patients receiving firs...

Descripción completa

Detalles Bibliográficos
Autores principales: Galli, Luca, Chiuri, Vincenzo Emanuele, Di Lorenzo, Giuseppe, Pisconti, Salvatore, Rossetti, Sabrina, Sirotova, Zuzana, Muto, Andrea, Petrioli, Roberto, De Tursi, Michele, Sbrana, Andrea, Francolini, Giulio, Ardizzoia, Antonio, Scavelli, Claudio, Satta, Francesco, Quadrini, Silvia, Airoldi, Mario, D’Aniello, Carmine, Bonetti, Andrea, Conforti, Serafino, Aieta, Michele, Beccaglia, Patrizia, Maestri, Antonio, Fratino, Lucia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070548/
https://www.ncbi.nlm.nih.gov/pubmed/35400269
http://dx.doi.org/10.1177/03008916221079662

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070548/
https://www.ncbi.nlm.nih.gov/pubmed/35400269
http://dx.doi.org/10.1177/03008916221079662

Ejemplares similares